Undecanoate

Undecanoate

SCHEMBL5527083

CCCCCCCCCCC(=O)O.[NaH]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.94
PPARG P37231 7/20 0.94
PPARD Q03181 7/20 0.94
PPARA Q07869 7/20 0.94
HDAC11 Q96DB2 5/20 0.94
TSHR P16473 4/20 0.94
PTPN1 P18031 3/20 0.94
FABP4 P15090 3/20 0.94
ALDH1A1 P00352 2/20 0.94
TLR2 O60603 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
KMT2A Q03164 2/20 0.94
ALOX15 P16050 2/20 0.94
HSD17B10 Q99714 2/20 0.94
SLC22A6 Q4U2R8 1/20 0.94
SLC22A8 Q8TCC7 1/20 0.94
MEN1 O00255 1/20 0.94
ESR1 P03372 1/20 0.94
PDE4A P27815 1/20 0.94
PDE3A Q14432 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dodecanoate SCHEMBL7062493 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL242161 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL24895 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL3972949 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL5144260 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL25434319 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL55414 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL16585379 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL11319185 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL14763615 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106974888-B Pharmaceutical composition and relevant medication 克艾思马有限公司 2019-08-02 CN claimed
CN-107989600-A A kind of water base trace chemistry tracer and the method for measuring water injection well inter well connectivity 北京捷贝通石油技术有限公司 2018-05-04 CN claimed
CN-102176900-B Pharmaceutical compositions and related methods of administration 克艾思马有限公司 2017-09-26 CN claimed
CN-106974888-A Pharmaceutical composition and related medication 克艾思马有限公司 2017-07-25 CN claimed
CN-102176900-A Pharmaceutical compositions and related methods of administration CHIASMA INC 2011-09-07 CN claimed
CN-106974888-B Pharmaceutical composition and relevant medication 克艾思马有限公司 2019-08-02 CN disclosed
CN-110062794-A Hard coating with high chemical and mechanical resistance 科思创德国股份有限公司 2019-07-26 CN disclosed
CN-108473659-A Method for producing porous material 巴斯夫欧洲公司 2018-08-31 CN disclosed
CN-107989600-A A kind of water base trace chemistry tracer and the method for measuring water injection well inter well connectivity 北京捷贝通石油技术有限公司 2018-05-04 CN disclosed
CN-107531703-A For treating the new dihydro pyrido isobioquin group and its pharmaceutical composition of diseases associated with inflammation 加拉帕戈斯股份有限公司 2018-01-02 CN disclosed
CN-102176900-B Pharmaceutical compositions and related methods of administration 克艾思马有限公司 2017-09-26 CN disclosed
CN-106974888-A Pharmaceutical composition and related medication 克艾思马有限公司 2017-07-25 CN disclosed
CN-102438451-B Composition containing sorbitan monocaprylate and alcohol CLARIANT FINANCE BVI LTD 2014-03-12 CN disclosed
CN-102176900-A Pharmaceutical compositions and related methods of administration CHIASMA INC 2011-09-07 CN disclosed
CN-101796024-A Stereoisomers of tricyclodecan-9-yl-xanthogenate SHOGOO PHARMACEUTICALS AG 2010-08-04 CN disclosed
US-7223775-B2 Stabilized ascorbic acid derivatives SHOWA DENKO K.K. (JP) 2007-05-29 US disclosed
US-20060100177-A1 Stabilized ascorbic acid derivatives SHOWA DENKO K.K. (JP) 2006-05-11 US disclosed
EP-1496889-A1 STABILIZED ASCORBIC ACID DERIVATIVES Showa Denko K.K. (JP) 2005-01-19 EP disclosed
WO-2003086384-A1 STABILIZED ASCORBIC ACID DERIVATIVES SHOWA DENKO K. K. (JP) 2003-10-23 WO disclosed
CN-1205030-A Machining fluid composition and method of machining CINCINNATI MILACRON INC (US) 1999-01-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100177-A1 Stabilized ascorbic acid derivatives RBP1, SOD1, PROC GPR84 3471/4885PPARG 2934/4885PPARD 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.